Home / Inspections / 1062223

FDA Inspection 1062223 — DOW LAO Blood Bank

DOW LAO Blood Bank — FEI 3008229902

The FDA completed an inspection of DOW LAO Blood Bank on June 28, 2018 in Plaquemine, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 28, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Plaquemine, LA (United States)

Facility

Other inspections at this facility

  • 1211182 (NAI Wed Jul 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 967541 (NAI Thu Apr 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 871324 (NAI Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 786396 (NAI Thu Jun 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 681928 (NAI Thu Sep 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources